Fifth Lane Capital’s Alimera Sciences ALIM Stock Holding History

Fifth Lane Capital’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-21,238	Closed	-$82.8K	–	185
2024 Q1	$82.8K	Buy	+21,238	New	+$80.8K	0.07%	97

Other funds holding ALIM

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fifth Lane Capital's ALIM Position: Q2 2024 in Review

Fifth Lane Capital sold out of Alimera Sciences (ALIM) in Q2 2024, closing a stake of 21,238 shares — an estimated $82.8K sold.

Fifth Lane Capital first reported a position in ALIM in Q1 2024 and held it in 1 quarter. The position peaked at $82.8K in Q1 2024. 52 funds tracked by Wall St. Rank hold ALIM as of Q2 2024.

Fifth Lane Capital reported no remaining Alimera Sciences position as of Q2 2024 after selling out during the quarter.
Fifth Lane Capital sold 21,238 Alimera Sciences shares in Q2 2024, an estimated $82.8K.
Fifth Lane Capital first reported a position in Alimera Sciences in Q1 2024 and held it in 1 quarter.
Fifth Lane Capital's Alimera Sciences position peaked at $82.8K in Q1 2024.
52 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2024.

Based on Fifth Lane Capital's 13F filing for Q2 2024, filed 14 Aug 2024.